We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHONY.L Regulatory News (HONY)

  • There is currently no data for HONY

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

NAV and Monthly Update - December 2020

12 Feb 2021 07:00

RNS Number : 8670O
Honeycomb Investment Trust PLC
12 February 2021
 

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA (OTHER THAN THE UNITED KINGDOM), CANADA, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL

12 February 2021

Honeycomb Investment Trust plc

Honeycomb Investment Trust plc (the "Company") announces that the Investment Manager's monthly factsheet for 31 December 2020 is now available on its website at http://www.honeycombplc.com.

Net Asset Value per Share

The Company announces that its unaudited Net Asset Value ("NAV") per share as at 31 December 2020 on a cum-income basis was 1,013.5 pence, based on a NAV of £357.2 million, and on an ex-income basis was 1,017.8 pence, based on a NAV of £358.9 million. The NAVs have been calculated by Apex Fund Services (UK) Ltd.

December Factsheet

Honeycomb Investment Trust plc (the "Company") delivered a NAV return of 0.67% for the month, which is equivalent to 7.9% per annum. This brings total NAV return for 2020 to 7.7%.

Alongside the strong return performance for the year the Company has also made significant progress in a number of other areas including moving to a main market listing, putting in place an active buyback program, diversifying the shareholder register and securing long term debt facilities. This leaves Honeycomb in a robust position heading into 2021.

2020 Performance and Portfolio

The portfolio has performed well throughout 2020 despite the challenging macro backdrop. This was demonstrated by a reduction in bad debts and impairments in the year with 1.0% charge on credit assets in 2020 vs 1.3% in 2019. This performance can be attributed to:

1) A focus on credit investments secured on loan portfolios of non-bank lenders with strong downside protection from senior ranking to the lender or borrower equity as well as security over the cashflow generated by the loan portfolio. This senior ranking provides insulation from increasing defaults in the portfolio and provides a stability of returns; and

 

2) Resilience exhibited by the specialty finance industry throughout COVID with cash collections from loan portfolios returning to pre-pandemic levels by Q3. We have also seen the significant majority of customers, who took payment holidays, return to full contractual payments.

The Company has also benefited from the decision taken at the beginning of 2019 to reduce the exposure to consumer direct unsecured loans where the Company owns the entire loan rather than having the senior exposure with the non-bank retaining the junior equity. Whilst the yield on these loans is higher the potential volatility, running impairments and cost to service means it is more attractive to reallocate the capital to secured exposures. This part of the portfolio has reduced to 6% at December 2020.

Investments assets finished the year at £571m which was broadly flat on prior year (Dec-19 £589m). Through the initial COVID period we reduced originations and stopped new investment activity and focused on portfolio management and cash collection to ensure robust performance. This resulted in the portfolio shrinking in Q2 and Q3 before seven new investment opportunities were completed in Q4.

Offsetting some of the strong performance in the asset portfolio was one off costs incurred in relation to the debt facilities. The existing debt facilities matured in April 2020 and due to the COVID pandemic the refinancing with a new bank was delayed. This meant that there was additional costs in extending the existing facility before a short term 12 month facility could be arranged. In September the Company completed its longer term (3 year) Topco facility with a European Bank. In addition, two other SPV financings were completed in the year meaning Honeycomb ended 2020 with long term and larger debt facilities providing a strong liquidity position and an ability to grow without further refinancing.

Embedding ESG through the Company

The Company's target markets have a strong positive ESG impact which have become ever more critical in the current environment in five key areas:

1) Lending to support SMEs and communities is ever more critical in the current environment and the Company works with lenders who are close to their customers and are able to offer tailored offerings to support them in a prudent way.

2) Our real estate lending strategy is critical to improving the quality of the property stock across the UK and Europe and the creation of affordable, efficient and good value homes.

3) Lending to support financial inclusion at a time when mainstream lenders are offering only the most vanilla automated products. Our partners that are nimble and work closely with customers are able to offer high quality lending offerings.

4) Lending to support improved energy efficiency in the home is one of the key ways that individuals can have a real positive impact on the environment. Starting with home improvements, this is now moving to the electrification of transport.

5) All our lending partners are required to demonstrate and embed the highest quality of governance and their own three lines of defence which we ensure is being complied with as part of our on-going monitoring.

Overall, the opportunity for specialist lenders with more nimble business models are able to work closely with customers, react quickly to the changing environment to create tailored and responsible lending products to support the economy in this challenging and dynamic environment.

 

 

 

 

 

This document is made available for information purposes only and does not contain any representations or constitute an offer to sell or the solicitation of an offer to acquire or subscribe for any securities of the Company. All investments are subject to risk. Prospective investors are advised to seek expert legal, financial, tax and other professional advice before making any investment decision. The value of investments may fluctuate and past performance is no guarantee of future results. 

For further information about this announcement please contact:

Pollen Street Capital - Investment Manager

Matthew Potter / Julian Dale: +44 (0)20 3728 6750

Liberum Capital Limited - Joint Broker

Chris Clarke / Louis Davies: +44 (0)20 3100 2000 

Cenkos Securities plc - Joint Broker

Justin Zawoda-Martin / Rob Naylor: +44 (0)20 7397 8900

Link Company Matters Limited - Corporate Secretary

Paul Johnston: +44 (0)20 7954 9552

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVMZGMZNMGGMZM
Date   Source Headline
7th Oct 20227:00 amRNSChange of Name
5th Oct 20225:11 pmRNSHolding(s) in Company
5th Oct 20225:11 pmRNSHolding(s) in Company
5th Oct 20225:07 pmRNSHolding(s) in Company
5th Oct 20225:04 pmRNSHolding(s) in Company
5th Oct 202212:01 pmRNSDirector/PDMR Shareholding
4th Oct 20226:23 pmRNSHolding(s) in Company
4th Oct 20225:44 pmRNSHolding(s) in Company
4th Oct 20225:10 pmRNSHolding(s) in Company
4th Oct 20224:53 pmRNSHolding(s) in Company
4th Oct 202212:07 pmRNSHolding(s) in Company
4th Oct 202211:29 amRNSHolding(s) in Company
30th Sep 20228:12 amRNSCompletion of the Combination with Pollen Street
26th Sep 20222:40 pmRNSPublication of a Prospectus
14th Sep 20224:44 pmRNSChange Of Latest DRIP Election Date
13th Sep 20227:45 amRNSHalf-year Report
6th Sep 20221:48 pmRNSDividend Declaration
6th Sep 20227:00 amRNSNAV and Monthly Update - July 2022
3rd Aug 20227:00 amRNSMonthly Update - June 2022
25th Jul 20227:00 amRNSAppointment of Corporate Broker
29th Jun 20227:00 amRNSTransaction in Own Shares and Total Voting Rights
28th Jun 20227:00 amRNSNAV and Monthly Update - May 2022
22nd Jun 20224:12 pmRNSResult of AGM
22nd Jun 20227:00 amRNSTransaction in Own Shares & Total Voting Rights
17th Jun 20227:00 amRNSTransaction in Own Shares and Total Voting Rights
1st Jun 20224:10 pmRNSResults of General Meeting
26th May 20227:00 amRNSNAV and Monthly Update – April 2022.
18th May 20224:22 pmRNSPosting of Annual Report and Notice of AGM
18th May 20227:00 amRNSTransaction in Own Shares and Total Voting Rights
10th May 20222:36 pmRNSCircular and Notice of General Meeting
6th May 20227:00 amRNSTransaction in Own Shares and Total Voting Rights
29th Apr 20227:00 amRNSShare Buyback Programme Extension
27th Apr 20227:00 amRNSMonthly Update - March 2022
26th Apr 20224:34 pmRNSDividend Declaration
7th Apr 20227:00 amRNSTransaction in Own Shares and Total Voting Rights
25th Mar 20227:00 amRNSTransaction in Own Shares and Total Voting Rights
21st Mar 20227:01 amRNSTransaction in Own Shares
21st Mar 20227:00 amRNSMonthly Update - February 2022
11th Mar 20223:21 pmRNSRussian Exposure
2nd Mar 20227:01 amRNSAnnual Financial Report
2nd Mar 20227:00 amRNSCapital Markets Day
2nd Mar 20227:00 amRNSStatement re Share Buyback
24th Feb 20227:00 amRNSNotice of upcoming Capital Markets Event
23rd Feb 20222:34 pmRNSDirector Declaration
23rd Feb 20222:28 pmRNSDividend Declaration
15th Feb 20227:00 amRNSHoneycomb combination with Pollen Street Capital
31st Jan 20227:00 amRNSMonthly Update - December 2021
23rd Dec 20217:00 amRNSNAV and Monthly Update - November 2021
24th Nov 20211:13 pmRNSDividend Declaration
23rd Nov 20217:00 amRNSNAV and Monthly Update - October 2021

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.